• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » California Life Sciences Assn. and OCTANe ink deal

California Life Sciences Assn. and OCTANe ink deal

August 17, 2016 By Fink Densford

OctaneThe California Life Sciences Association today said it inked a deal with Orange County life science and tech accelerator OCTANe to “accelerate the growth of Orange County’s life sciences sector.”

Through the deal, the CLSA will provide multi-faceted support to OCTANe stakeholders, including state and federal advocacy services, public policy roundtables and industry programs and conferences.

“We are thrilled to further extend our statewide resources and capabilities into Orange County to intensify the investment and innovation in their life sciences cluster. California’s life sciences ecosystem, as exemplified in and around Orange County, is driving the economy and delivering life-changing medicines and technologies that benefit overall health and well-being. For the sector to continue flourishing, we need to strengthen and facilitate life sciences research, investment and entrepreneurship to move new ideas forward. This collaboration aims to empower both CLSA and OCTANe members by providing key statewide resources and tools necessary to succeed,” CLSA CEO & prez Sara Radcliffe said in a press release.

Members of OCTANe will also be eligible to use CLSA’s business solutions program, which includes $100 million in funds and discounts on services from lab supplies to healthcare benefits, the groups said.

“Considering the demands of Southern California’s emerging life sciences industry, this partnership with the California Life Sciences Association is based on the simple notion of providing companies what they want in order to grow and expand their business. This alliance is further proof of OCTANe’s mission to connect people and ideas with resources and capital. By providing this additional suite of services to our early-stage companies, we will support the sustained growth of our thriving life sciences community,” OCTANe CEO Bill Carpou said in prepared remarks.

“This partnership shines a brighter light on the important work happening in Orange County’s life sciences community, which is impacting patients all around the world, and allows emerging life sciences companies the opportunity to participate in state and federal legislation as part of the greater voice of California’s biomedical industry,” Edwards Lifesciences strategy & corp dev corporate veep Donald Bobo, Jr. said in a prepared release.

In February, OCTANe said it launched the Visionary Venture Fund and Advisory Board, a $50 million venture fund that aims to boost ophthalmology innovation and development in Orange County, Calif. and in the wider medical industry.

The fund will support select startup companies through both monetary support and counsel from experts in the ophthalmology field, according to Aliso Viejo, Calif.-based OCTANe. More than 20 ophthalmology industry experts will aid later-stage startups in navigating from the initial funding and development stages through to commercialization.

Filed Under: Business/Financial News, Research & Development Tagged With: OCTANe

More recent news

  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy